Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Finished Goods (2021 - 2022)

Pulse Biosciences has reported Finished Goods over the past 2 years, most recently at $750000.0 for Q3 2022.

  • Quarterly results put Finished Goods at $750000.0 for Q3 2022, down 55.91% from a year ago — trailing twelve months through Sep 2022 was $750000.0 (down 55.91% YoY), and the annual figure for FY2021 was $2.4 million, changed.
  • Finished Goods for Q3 2022 was $750000.0 at Pulse Biosciences, down from $2.6 million in the prior quarter.
  • Over the last five years, Finished Goods for PLSE hit a ceiling of $2.7 million in Q1 2022 and a floor of $750000.0 in Q3 2022.